Pregabalin
Spinal Cord Injury
Ju Seok RyuSmall moleculePhase 4 / ApprovedDormant
BBB
75/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 62/ 100
- Competitive Position
- 95/ 100
Competitive context
19 Active assets in the Spinal Cord Injury cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Gabapentin MetroHealth Medical Center | Phase 4 | BB |
Semaglutide James J. Peters Veterans Affairs Medical Center | Phase 4 | BB |
VENLOR University of Washington | Phase 4 | BB |
Amitriptyline Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 4 | BB |
Brivaracetam University of Minnesota | Phase 3 | BB |
View all 42 →
Same molecule, other indications
Pregabalin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →